What are the side effects of using an EpiPen (epinephrine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Side Effects of EpiPen (Epinephrine)

The most common side effects of EpiPen (epinephrine) include transient anxiety, fear, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea, vomiting, headache, and respiratory difficulties. 1

Common Side Effects

Epinephrine has a narrow therapeutic-to-toxic index (risk-to-benefit ratio). When administered at therapeutic doses, epinephrine commonly causes mild and transient adverse effects including:

  • Cardiovascular effects:

    • Palpitations
    • Increased heart rate
    • Pallor
  • Neurological effects:

    • Anxiety
    • Restlessness
    • Tremor
    • Dizziness
    • Headache
  • Other effects:

    • Sweating
    • Nausea and vomiting
    • Weakness

These symptoms are expected physiological responses to epinephrine and typically resolve quickly as the medication is metabolized. They occur due to epinephrine's stimulation of alpha and beta-adrenergic receptors throughout the body 2, 1.

Serious Side Effects

While rare, serious adverse effects can occur, particularly in certain high-risk populations:

  • Cardiovascular complications:

    • Ventricular arrhythmias
    • Angina
    • Myocardial infarction
    • Pulmonary edema
    • Sudden increases in blood pressure (potentially leading to cerebral hemorrhage, particularly in elderly patients with cardiovascular disease)
    • Tachyarrhythmias 2, 1
  • Other serious effects:

    • Injection site reactions (if accidentally injected into digits, hands, or feet)
    • Tissue damage or injury at injection site
    • Rare cases of serious skin and soft tissue infections 1

Risk Factors for Adverse Effects

Certain populations are at higher risk for experiencing adverse effects:

  • Patients with heart disease
  • Patients with hypertension
  • Patients with hyperthyroidism
  • Elderly patients
  • Patients with Parkinson's disease
  • Patients with diabetes
  • Patients with pheochromocytoma 2, 1

Route of Administration and Side Effects

The route of administration significantly impacts the risk of adverse effects:

  • Intramuscular (IM) injection (recommended route):

    • Lower risk of cardiovascular complications (1.3% risk)
    • Lower risk of overdose 3
  • Intravenous (IV) bolus (not recommended for standard use):

    • Significantly higher risk of cardiovascular complications (10% risk)
    • Higher risk of overdose (13.3% risk) 3

Important Considerations

  1. Despite potential side effects, epinephrine is the first-line treatment for anaphylaxis with no absolute contraindications in a life-threatening situation 2, 4

  2. Even patients with cardiovascular disease should receive epinephrine for anaphylaxis because the risk of untreated anaphylaxis exceeds the risk of epinephrine's cardiac effects 2, 5

  3. Between 6-19% of pediatric patients and up to 20% of all patients may require a second dose of epinephrine if symptoms persist or recur 2, 6

  4. Proper administration technique is crucial to minimize side effects:

    • Inject into the anterolateral thigh (vastus lateralis muscle)
    • Never inject into buttocks, digits, hands, or feet to avoid tissue damage 1

Dosing Considerations

  • Adults and children ≥30 kg: 0.3-0.5 mg (0.3-0.5 mL of 1:1000 solution)
  • Children <30 kg: 0.01 mg/kg up to 0.3 mg (0.01 mL/kg of 1:1000 solution) 4

For children weighing 15-30 kg, studies have shown that the EpiPen (0.3 mg) compared to EpiPen Jr (0.15 mg) results in higher systolic blood pressure and more adverse effects, though both achieve similar plasma concentrations 7.

While side effects can occur, they are generally outweighed by the life-saving benefits of epinephrine in anaphylaxis, and delayed administration is associated with poorer outcomes and increased mortality.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anaphylaxis and cardiovascular disease: therapeutic dilemmas.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2015

Research

EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis.

The Journal of allergy and clinical immunology, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.